The effects of Nebivolol/HCTZ on Central Arterial Pressure, a randomised double-blind cross-over trial.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2013
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Metoprolol
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms NeMeCAP
- Sponsors Menarini Benelux
- 17 Jun 2013 Primary endpoint 'Central-systolic-blood-pressure' has not been met.
- 17 Jun 2013 Primary endpoint 'Blood-pressure' has not been met.
- 17 Jun 2013 Primary endpoint 'Augmentation-index' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History